References
- Saus J, Wieslander J, Langeveld JP, et al. Identification of the Goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem. 1988;263:13374–13380.
- Turner N, Mason PJ, Brown R, et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest. 1992;89:592–601.
- Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–432.
- Marra A, Vargas M, Striano P, et al. Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses. 2014;82:619–622.
- Cha B, Kim DY, Jang H, et al. Unusual case of posterior reversible encephalopathy syndrome in a patient with anti-glomerular basement membrane antibody glomerulonephritis: a case report and review of the literature. Electrolyte Blood Press. 2017;15:12–16.
- Ozkok A, Elcioglu OC, Bakan A, et al. Reversible posterior leukoencephalopathy in the course of Goodpasture syndrome. Ren Fail. 2012;34:254–256.
- Abenza-Abildua MJ, Fuentes B, Diaz D, et al. Cyclophosphamide-induced reversible posterior leukoencephalopathy syndrome. BMJ Case Rep. 2009;2009.
- Nisar T, Alchaki AR, Feinstein E. A rare case of cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with anti-GBM vasculitis, and review of current literature. Case Rep Neurol Med. 2019;2019:2418597.
- Gutiérrez-Sánchez MJ, Petkov-Stoyanov V, Martín-Navarro JA. Reversible posterior leukoencephalopathy syndrome in Goodpasture syndrome. Nefrologia. 2012;32:540–541.
- Ge YT, Liao JL, Liang W, et al. Anti-glomerular basement membrane disease combined with IgA nephropathy complicated with reversible posterior leukoencephalopathy syndrome: an unusual case. Am J Case Rep. 2015;16:849–853.
- Camara-Lemarroy CR, Cruz-Moreno MA, Gamboa-Sarquis RN, et al. Goodpasture syndrome and posterior reversible encephalopathy syndrome. J Neurol Sci. 2015;354:135–137.
- Lahmer T, Küchle C, Schirmer L, et al. Kidney transplant after preexisting posterior reversible encephalopathy syndrome induced by Goodpasture’s syndrome. Exp Clin Transplant. 2012;10:299–301.
- Preul C, Gerth J, Lang S, et al. Cerebral involvement in a patient with Goodpasture’s disease due to shortened induction therapy: a case report. J Med Case Rep. 2009;3:120.
- Kim JY, Ahn KJ, Jung JI, et al. Imaging findings of central nervous system vasculitis associated with Goodpasture’s Syndrome: a case report. Korean J Radiol. 2007;8:545–547.
- Gittins N, Basu A, Eyre J, et al. Cerebral vasculitis in a teenager with Goodpasture’s syndrome. Nephrol Dial Transplant. 2004;19:3168–3171.
- Yahata M, Nakaya I, Soma J. A case of anti-glomerular basement membrane glomerulonephritis showing central nervous system involvement. Nihon Toseki Igakkai Zasshi. 2010;43:601–608.
- Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol. 2002;23:1038–1048.
- Rochfort KD, Collins LE, Murphy RP, et al. Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One. 2014;9:e101815.
- Pedchenko V, Bondar O, Fogo AB, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363:343–354.
- Zhao J, Cui Z, Yang R, et al. Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity. Kidney Int. 2009;76:1108–1115.